T. Rowe Price Associates »

Apogee Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $22M 771k 27.94
2023-09-30 $13M 616k 21.30

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Apogee Therapeutics

VR Adviser
Fairmount Funds Management
RA Capital Management
Vanguard Group
Perceptive Advisors
Wellington Management Company
OrbiMed Advisors
Franklin Resources
T. Rowe Price Associates
Point72 Asset Management
Braidwell
Bank of America Corporation
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management

View all funds holding Apogee Therapeutics